Infections, low IgG ‘common’ in children on rituximab
Boston hospital study suggests corticosteroids compound the risk, researchers say.
A significant proportion of children and young adults with rheumatological diseases develop new-onset hypogammaglobulinaemia and infections following treatment with rituximab, US researchers report.
Furthermore, exposure to a pulse of corticosteroids appears to raise the odds of such complications, they say.
